Chelsea Handler said that this $13 hydrating lotion is ‘like an elixir’ for her dry skin and it’s on Amazo — details!

Dive deeper into "The Tell," Oprah's latest book club selection, with the "CBS Mornings" reading group discussion guide.

A newly pregnant New Jersey teacher recently shared the news to her AP Chemistry students — with a chemistry assignment of ...

One woman felt like it might be time for her husband to move out after learning more about his questionable hygiene habits.

Hims & Hers (NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the week. Several analysts raised their price targets on the specialty ...

He’s one proud husband. Kanye West shared an image of his unclothed wife, Bianca Censori, to promote her new film. In the poster for the forthcoming movie, the Australian model was seen lying on ...

Hims & Hers Health's stock has surged 205% since my last 'Buy' rating, but its valuation is now stretched, prompting a downgrade to 'Hold'. Some risks include Amazon's aggressive telehealth entry ...

FDA's update led to renewed uncertainty for a growing group of telehealth companies such as Hims & Hers that have built businesses around offering cheaper copies of the branded medications.

Bank of America raised its price target on Hims & Hers stock today, but still thinks it costs twice what it should. At 77 times predicted 2027 earnings, Hims & Hers stock looks too expensive to buy.

Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more precise clinical decision-making. Hims & Hers Health, Inc. is acquiring Kearny, ...

The company has acquired an at-home lab testing facility, Sigmund NJ LLC marketed as Trybe Labs, which will allow Hims & Hers to support at-home blood draws and more comprehensive whole body testing.